Risk stratification of hepatocellular carcinoma in patients with chronic liver disease by combining gadolinium‐ethoxybenzyl diethylenetriamine‐pentaacetic acid–enhanced magnetic resonance imaging and magnetic resonance elastography
E. Meren, Yoshiyuki Sawai, K. Fukuda, T. Igura, S. Kogita, Yoshihiro Yukimura, Y. Seki, Norihiko Fujita, M. Oshita, Y. Imai
{"title":"Risk stratification of hepatocellular carcinoma in patients with chronic liver disease by combining gadolinium‐ethoxybenzyl diethylenetriamine‐pentaacetic acid–enhanced magnetic resonance imaging and magnetic resonance elastography","authors":"E. Meren, Yoshiyuki Sawai, K. Fukuda, T. Igura, S. Kogita, Yoshihiro Yukimura, Y. Seki, Norihiko Fujita, M. Oshita, Y. Imai","doi":"10.1002/ygh2.495","DOIUrl":null,"url":null,"abstract":"Liver stiffness (LS) as measured by magnetic resonance elastography (MRE) and the presence of intrahepatic nonhypervascular hypointense nodules (NHHNs) during the hepatobiliary phase of gadolinium‐ethoxybenzyl diethylenetriamine‐pentaacetic acid–enhanced magnetic resonance imaging are non‐invasive MR‐based biomarkers of hepatocarcinogenesis.","PeriodicalId":12480,"journal":{"name":"GastroHep","volume":"1 1","pages":"435 - 442"},"PeriodicalIF":0.0000,"publicationDate":"2021-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"GastroHep","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/ygh2.495","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Liver stiffness (LS) as measured by magnetic resonance elastography (MRE) and the presence of intrahepatic nonhypervascular hypointense nodules (NHHNs) during the hepatobiliary phase of gadolinium‐ethoxybenzyl diethylenetriamine‐pentaacetic acid–enhanced magnetic resonance imaging are non‐invasive MR‐based biomarkers of hepatocarcinogenesis.